These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37378386)

  • 1. An endoscopic and histopathological assessment and correlation of endoscopic score with clinical activity index (CIBDAI) in the diagnosis of canine idiopathic inflammatory bowel disease.
    Sandhya Bhavani M; Kavitha S; Nagarajan B; Pazhanivel N; Vairamuthu S; Bhat AA
    Iran J Vet Res; 2023; 24(1):58-64. PubMed ID: 37378386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
    Münster M; Hörauf A; Bilzer T
    Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A scoring index for disease activity in canine inflammatory bowel disease.
    Jergens AE; Schreiner CA; Frank DE; Niyo Y; Ahrens FE; Eckersall PD; Benson TJ; Evans R
    J Vet Intern Med; 2003; 17(3):291-7. PubMed ID: 12774968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlating Gastrointestinal Histopathologic Changes to Clinical Disease Activity in Dogs With Idiopathic Inflammatory Bowel Disease.
    Allenspach KA; Mochel JP; Du Y; Priestnall SL; Moore F; Slayter M; Rodrigues A; Ackermann M; Krockenberger M; Mansell J; ; Luckschander N; Wang C; Suchodolski J; Berghoff N; Jergens AE
    Vet Pathol; 2019 May; 56(3):435-443. PubMed ID: 30563436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease.
    Heilmann RM; Grellet A; Allenspach K; Lecoindre P; Day MJ; Priestnall SL; Toresson L; Procoli F; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):156-66. PubMed ID: 24518653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease.
    Luckschander N; Allenspach K; Hall J; Seibold F; Gröne A; Doherr MG; Gaschen F
    J Vet Intern Med; 2006; 20(2):221-7. PubMed ID: 16594575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an endoscopic activity score for canine inflammatory bowel disease.
    Slovak JE; Wang C; Sun Y; Otoni C; Morrison J; Deitz K; LeVine D; Jergens AE
    Vet J; 2015 Mar; 203(3):290-5. PubMed ID: 25665921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2/caspase 3 mucosal imbalance favors T cell resistance to apoptosis in dogs with inflammatory bowel disease.
    Jergens A; Young J; Moore D; Wang C; Hostetter J; Augustine L; Allenspach K; Schmitz S; Mosher C
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):167-74. PubMed ID: 24495616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease.
    Otoni CC; Heilmann RM; García-Sancho M; Sainz A; Ackermann MR; Suchodolski JS; Steiner JM; Jergens AE
    J Vet Intern Med; 2018 May; 32(3):999-1008. PubMed ID: 29624721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial.
    Jergens AE; Crandell J; Morrison JA; Deitz K; Pressel M; Ackermann M; Suchodolski JS; Steiner JM; Evans R
    J Vet Intern Med; 2010; 24(2):269-77. PubMed ID: 20051005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic mucosal and cytobrush sample cytokine mRNA expression in canine inflammatory bowel disease and their correlation with disease activity, endoscopic and histopathologic score.
    Konstantinidis AO; Adamama-Moraitou KK; Pardali D; Dovas CI; Brellou GD; Papadopoulos T; Jergens AE; Allenspach K; Rallis TS
    PLoS One; 2021; 16(1):e0245713. PubMed ID: 33471872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Ricciuto A; Fish J; Carman N; Walters TD; Church PC; Hansen BE; Crowley E; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1098-1105.e1. PubMed ID: 29378308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic characterization of canine intestinal intraepithelial lymphocytes in dogs with inflammatory bowel disease.
    Haas E; Rütgen BC; Gerner W; Richter B; Tichy A; Galler A; Bilek A; Thalhammer JG; Saalmüller A; Luckschander-Zeller N
    J Vet Intern Med; 2014; 28(6):1708-15. PubMed ID: 25250556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, controlled trial evaluating the effect of multi-strain probiotic on the mucosal microbiota in canine idiopathic inflammatory bowel disease.
    White R; Atherly T; Guard B; Rossi G; Wang C; Mosher C; Webb C; Hill S; Ackermann M; Sciabarra P; Allenspach K; Suchodolski J; Jergens AE
    Gut Microbes; 2017 Sep; 8(5):451-466. PubMed ID: 28678609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A correlation between the canine Inflammatory Bowel Disease Activity Index score and the histopathological evaluation of the small intestinal mucosa in canine inflammatory bowel disease.
    Rychlik A; Nieradka R; Kander M; Nowicki M; Wdowiak M; Kołodziejska-Sawerska A
    Pol J Vet Sci; 2012; 15(2):315-21. PubMed ID: 22844710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial.
    Segarra S; Martínez-Subiela S; Cerdà-Cuéllar M; Martínez-Puig D; Muñoz-Prieto A; Rodríguez-Franco F; Rodríguez-Bertos A; Allenspach K; Velasco A; Cerón J
    BMC Vet Res; 2016 Mar; 12():49. PubMed ID: 26965834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, endoscopic and histopathological evaluation of the efficacy of budesonide in the treatment of inflammatory bowel disease in dogs.
    Rychlik A; Kołodziejska-Sawerska A; Nowicki M; Szweda M
    Pol J Vet Sci; 2016; 19(1):159-64. PubMed ID: 27096800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical signs, duodenal histopathological grades, and serum high-mobility group box 1 concentrations in dogs with inflammatory bowel disease.
    Lee JH; Kim HS; Lee D; Yun T; Koo Y; Chae Y; Kang JH; Kang BT; Yang MP; Kim H
    J Vet Intern Med; 2021 Sep; 35(5):2205-2214. PubMed ID: 34480505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
    Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel diseases].
    Pytrus T; Mowszet K; Krzesiek E; Rzeszutko M; Iwańczak B
    Pol Merkur Lekarski; 2008 Dec; 25(150):460-4. PubMed ID: 19205374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.